Multinational phase II study of navelbine (N) and herceptin (H) as first-line trerapy for HER2-overexpressing metastatic breast Cancer (HER2+MBC) | Charles Explorer

Multinational phase II study of navelbine (N) and herceptin (H) as first-line trerapy for HER2-overexpressing metastatic breast Cancer (HER2+MBC)

Publikace

Abstrakt

Navelbine (N) and herceptin, metastatic breast cancer

Osoby